RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Experimental Colitis
Accession: DOID:9000099
browse the term
Definition: Colitis induced experimentally in laboratory animals by administration of various agents such as dextran sulfate sodium (DSS), 2,4,6-trinitrobenzene sulfonic acid (TNBS), or acetic acid. Experimental colitis can also be induced by a procedure like colon diversion or radiation treatment.
G
Ace
angiotensin I converting enzyme
treatment
ISO
RGD
PMID:24239644 PMID:17342403
RGD:40400720 , RGD:40400748
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Acer3
alkaline ceramidase 3
severity
ISO
mRNA,protein:decreased expression, decreased activity:colon:
RGD
PMID:26938296 PMID:26938296
RGD:35673322 , RGD:35673322
NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
G
Adam17
ADAM metallopeptidase domain 17
treatment
IEP
RGD
PMID:11884025
RGD:632022
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
G
Adrb3
adrenoceptor beta 3
no_association
IEP
mRNA:unaltered expression:colon (rat)
RGD
PMID:11803250
RGD:5684894
NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
G
Ager
advanced glycosylation end product-specific receptor
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Akt1
AKT serine/threonine kinase 1
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Atm
ATM serine/threonine kinase
exacerbates
ISO
RGD
PMID:20179206
RGD:126781749
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atp5f1a
ATP synthase F1 subunit alpha
treatment
IEP
RGD
PMID:25689466
RGD:13703055
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Birc3
baculoviral IAP repeat-containing 3
exacerbates
ISO
RGD
PMID:26037070
RGD:11537970
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Cd68
Cd68 molecule
treatment
ISO
RGD
PMID:25004394
RGD:40925931
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
treatment
IMP
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
G
Csf1r
colony stimulating factor 1 receptor
ameliorates
ISO
RGD
PMID:23451116
RGD:150524300
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:16689657
RGD:11039462
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Ereg
epiregulin
ISO
protein:increased expression:colonic mucosa (mouse)
RGD
PMID:20498653
RGD:39457688
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
treatment
ISO
RGD
PMID:31160593
RGD:126779602
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
Fas
Fas cell surface death receptor
treatment
IDA
RGD
PMID:22368862
RGD:10054108
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fgf10
fibroblast growth factor 10
treatment
ISO IDA
human protein in mouse model human protein in mouse model with bacterial delivery system human gene product in mouse model
RGD
PMID:10381813 PMID:19736360 PMID:23676805 PMID:11952999
RGD:126928132 , RGD:126928133 , RGD:127284855 , RGD:127284874
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
G
Fgf7
fibroblast growth factor 7
treatment
ISO
human protein in mouse model
RGD
PMID:10219846
RGD:126928136
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Foxp3
forkhead box P3
treatment
ISO IDA
protein:increased expression:colon: mRNA:increased expression:mucosa:
RGD
PMID:26925602 PMID:17229795 PMID:27498708 PMID:28733028
RGD:38455994 , RGD:38455995 , RGD:14975101 , RGD:38549362
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Hamp
hepcidin antimicrobial peptide
IEP
protein:increased expression:colon
RGD
PMID:24764672
RGD:11041628
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Hmgb1
high mobility group box 1
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hsf1
heat shock transcription factor 1
IEP
protein:increased acetylation:colon (rat)
RGD
PMID:25608526
RGD:10402402
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Icam1
intercellular adhesion molecule 1
treatment
IMP IEP
RGD
PMID:10092309 PMID:29572553
RGD:11522714 , RGD:152995414
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifng
interferon gamma
IEP ISO
protein:increased expression:plasma:
RGD
PMID:15030379 PMID:27498708
RGD:10755756 , RGD:14975101
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifngr1
interferon gamma receptor 1
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Il10
interleukin 10
treatment
ISO IEP
associated with Helicobacter Infections
RGD
PMID:16982822 PMID:25727887 PMID:27815529 PMID:29572553
RGD:11049170 , RGD:11049485 , RGD:14975260 , RGD:152995414
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
treatment
ISO
RGD
PMID:31175857
RGD:14975282
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:8978354
RGD:8551835
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
IEP
RGD
PMID:16630696
RGD:8662978
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il23a
interleukin 23 subunit alpha
severity
ISO
mRNA:increased expression:colon (mouse)
RGD
PMID:24028683
RGD:39458035
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il25
interleukin 25
treatment
ISO
RGD
PMID:19118508
RGD:39456129
NCBI chr15:28,408,766...28,412,157
Ensembl chr15:28,408,842...28,411,893
G
Il33
interleukin 33
severity treatment
ISO
RGD
PMID:25112700 PMID:28423665
RGD:39938951 , RGD:39939041
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il6
interleukin 6
treatment
IEP IDA ISO
RGD
PMID:16630696 PMID:16133010 PMID:27096537
RGD:8662978 , RGD:11062139 , RGD:11062146
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf9
interferon regulatory factor 9
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
G
Itga2
integrin subunit alpha 2
treatment
ISO
RGD
PMID:16534417
RGD:11530069
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itga4
integrin subunit alpha 4
IEP
protein:increased expression:colon (rat)
RGD
PMID:12183646
RGD:729408
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Jak2
Janus kinase 2
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
IEP
mRNA, protein:increased expression:colon
RGD
PMID:23986198
RGD:10412026
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
G
Kdr
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kl
Klotho
ISO
mRNA:decreased expression:kidney:
RGD
PMID:20004202
RGD:10403055
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Mapk1
mitogen activated protein kinase 1
treatment
IEP
RGD
PMID:27028006
RGD:13800882
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
RGD
PMID:29037916
RGD:13800567
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mif
macrophage migration inhibitory factor
severity
ISO
RGD
PMID:15807847
RGD:36947390
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mir146a
microRNA 146a
ISO
miRNA:increased expression:colon, small intestine (mouse)
RGD
PMID:24092752
RGD:126925183
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir155
microRNA 155
treatment
ISO IMP
associated with Helicobacter Infections
RGD
PMID:30927737 PMID:28246471 PMID:21880981 PMID:30253332 PMID:28752563 PMID:28461115 More...
RGD:21079443 , RGD:21079463 , RGD:21079473 , RGD:21081536 , RGD:24922208 , RGD:25314295
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
ameliorates
ISO
RGD
PMID:23826144
RGD:41404691
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mmp2
matrix metallopeptidase 2
treatment
IEP
RGD
PMID:23323009
RGD:13207328
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
treatment
IEP
RGD
PMID:23323009
RGD:13207328
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Myd88
MYD88, innate immune signal transduction adaptor
exacerbates
ISO
RGD
PMID:25362351
RGD:150521530
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:22350949
RGD:10412739
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
treatment
IDA
RGD
PMID:21642017
RGD:10413866
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nod2
nucleotide-binding oligomerization domain containing 2
IEP
protein:increased expression:colonic mucosa:
RGD
PMID:22997830
RGD:13204727
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Npy
neuropeptide Y
treatment
IMP
RGD
PMID:20533056
RGD:10448943
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Pdgfra
platelet derived growth factor receptor alpha
treatment
IEP
RGD
PMID:24115822
RGD:11080973
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
treatment
IEP
RGD
PMID:24115822
RGD:11080973
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Phex
phosphate regulating endopeptidase X-linked
ISO
mRNA:decreased expression:bone:
RGD
PMID:16890604
RGD:11556253
NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
susceptibility
ISO
RGD
PMID:20347874
RGD:38599183
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
G
Ptger4
prostaglandin E receptor 4
treatment
IMP
RGD
PMID:12100473
RGD:727388
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Rela
RELA proto-oncogene, NF-kB subunit
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rnasel
ribonuclease L
severity
ISO
RGD
PMID:23567782
RGD:40902808
NCBI chr13:65,894,990...65,910,354
Ensembl chr13:65,901,459...65,908,704
G
Slc11a1
solute carrier family 11 member 1
ISO
RGD
PMID:19116231
RGD:5684934
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Smad4
SMAD family member 4
susceptibility
ISO
RGD
PMID:23090737
RGD:12880038
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
G
Socs3
suppressor of cytokine signaling 3
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Tnf
tumor necrosis factor
treatment
IMP IEP
RGD
PMID:21296062 PMID:29572553
RGD:8661763 , RGD:152995414
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
IMP
RGD
PMID:21296062
RGD:8661763
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all